Growth inhibition and induction of apoptosis by 2-deoxy-D-glucose in human squamous carcinoma cell lines

Biomedicine

Volumn 24, Issue 3-4, 2004, Pages 36-47

  Dwarakanath, B S ^a   Adhikari, J S ^a   Khaitan, Divya ^a   Chandna, Sudhir ^a   Mathur, Rohit ^a,b   Ravindranath, T ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEOXYGLUCOSE; GLUCOSE; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSTASIS; CYTOTOXICITY; GLUCOSE UTILIZATION; GLYCOLYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 15344347645     PISSN: 09702067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Warburg, O. On the origin of cancer cells. Science 123: 309-314; 1956.
2. Aisenberg, A.C. The glycolysis and respiration of tumors. Acad Press 1961.
3. Weber G. Enzymology of cancer cells. New Eng. J. Med. 296: 541-551; 1977.
4. Birnbaum, M.J.; Haspel, H.C. and Rosen, O.M. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 235: 1495-1498; 1987.
5. Yamamoto, T.; Seino, Y.; Fukumoto, H. et al. Over-expression of facultative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170: 223-230; 1990.
6. Johansson, T.; Berez, J.M. and Nelson, D. Evidence that transcription of the rat hexokinase gene is increase in a rapidly growing rat hepatoma. Biochem. Biophys. Res. Commun. 133: 608-613; 1985.
7. Rempel, A.; Bannasch, P. and Mayer, D. Difference in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim Biophys. Acta. 1219: 660-668; 1994.
8. Weinhouse, S. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas. Cancer Res. 32: 2007-2016; 1972.
9. Dang, C.C. and Semenza, G.L. Oncogenic alterations of metabolism. Elsevier Science, 68-72; 1999.
10. Dichiro, G.; Brooks, R.A. and Patronas, N.T. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann. Neurol. 15: S138-S146; 1984.
11. Padma, M.V.; Said, S. and Jacobs, M. Prediction of pathology and survival by FDG PET in gliomas. J. Neurooncol. 64: 227-237; 2003.
12. Shim, H., Chun, Y. S., Lewis, B. C. and Dang, Chi. V. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. 95: 1511-1516; 1998.
13. Woodward, G.E. and Hudson, M.T. The effect of 2-deoxy-D-glucose on glycolysis and respiration of tumor and normal tissues. Cancer Res 1954; 14: 599-605.
14. Wick, A.N.; Dury, D. and Nakada, H.I. Localization of the primary metabolic block produced by 2-deoxy-D-glucose. J. Biol. Chem. 224: 963-969; 1957.
15. Nirenberg, M.W. and Hogg, J.F. Inhibition of anaerobic glycolysis in Ehrlich ascites tumor cells by 2-DG. Cancer Res. 18: 518; 1958.
16. McComb, R.B. and Yushok, W.D. Metabolism of ascites tumor cells III effects of 2-deoxy-D-glucose phosphorylation on phosphorous metabolism. Cancer Res. 24: 193-197; 1964.
17. Dwarakanath B.S. and Jain V.K. Energy linked modifications of the radiation response in a Human Cerebral Glioma Cell Line. Int. J. Radiat. Oncol. Biol. Phys. 17: 1033-1040; 1989.
18. Dwarakanath B.S. and Jain, V.K. Effects of gamma- rays and glucose analogs on the energy metabolism of a cell line derived from human cerebral glioma. Ind. J. Biochem. Biophys. 28: 203-209; 1991.
19. Barban, S. and Schulz, H.O. The effects of 2-deoxy-D-glucose on the growth and metabolism of cultured human cells. J. Biol. Chem. 276: 1887-1890; 1961.
20. Purohit, S.C. and Pohlit, W. Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors. I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and growth of solid tumors after 2-DG and X-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 8: 495-499; 1982.
21. Kern, K.A. and Nortan, J.A. Int. of rat fibrosarcoma growth by 2-DG. Surgery 102: 380-385; 1987.
22. Gupta, S.; Mathur, R. and Dwarakanath, B. S. Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors. Biomedicine In Press; 2004.
23. Jain, V.K.; Gupta, I. and Lata, K. Energetics of cellular repair processes in a respiratory-deficient mutant of yeast. Radiat. Res. 92: 463-473; 1982.
24. Frankenberg-Schwager M.; Harbich, R. and Frankenberg D. 2-Deoxy-D-glucose inhibits rejoining of radiation-induced DNA double-strand breaks in yeast. Int. J. Radiat. Biol. 61: 185-190; 1992.
25. Jain, V.K.; Purohit, S.C. and Pohlit, W. Inhibition of repair of X-ray induced potentially lethal X-ray damage by 2-deoxy-D-glucose in Ehrlich ascites tumor cells. Ind. J. Expt. Biol. 15: 711-713; 1977.
26. Jain, V.K.; Kalia, V.K. and Sharma, R. Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 11: 943-950; 1985.
27. Jha, B. and Pohlit, W. Effect of 2-deoxy-D-glucose on DNA double strand break repair, cell survival and energy metabolism in euoxic Ehrlich ascites tumor cells. Int. J. Radiat. Biol. 62: 409-415; 1992.
28. Dwarakanath, B.S.; Zolzer, F. and Chandna, S. Heterogeniety in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 50: 1051-1061; 2001.
29. Dwarakanath, B.S. and Jain, V.K. Enhancement of the radiation damage by 2-deoxy-D-glucose in organ culture of brain tumor. Ind. J. Med. Res. 82: 266-268; 1985.
30. Dwarakanath, B.S. and Jain, V.K. Modification of the radiation induced damage by 2-deoxy-D-glucose in organ cultures of human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 13: 741-746; 1987.
31. Dwarakanath, B. S., Khaitan, D. and Mathur, R. Topoisomerase inhibitors as anticancer drugs: Problems and prospects. Ind. J. Expt. Biol. 42: 649-659; 2004.
32. Dwarakanath, B.S.; Khaitan, D. and Ravindranath, T. 2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines. Cancer Biol. Ther. 39: 11-17; 2004.
33. Kalia, V.K.; Jain, V.K. and Otto, F.J. Optimization of cancer therapy: Part IV-Effects of 2-deoxy-D-glucose on radiation-induced chromosomal damage in PHA stimulated peripheral leukocytes. Ind. J. Expt. Biol. 20: 884-888, 1982.
34. Swamy, R.K.; Manickam, J. and Adhikari, J.S. The glycolytic inhibitor 2-deoxy-D-glucose does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro. Ind. J. Expt. Biol. Communicated; 2004.
35. Mohanti, B.K.; Rath, G.K. and Anantha, N. Improving cancer radiotherapy with 2-deoxy-D-glucose: Phase I/II clinical trial on human cerebral glioma. Int. J. Radiat. Oncol. Biol. Phys. 35: 103-111; 1996.
36. Adhikari, J.S.; Dwarakanath, B.S.; Mathur, R. and Ravideranath, T. Alterations in radiation induced cell cycle perturbations by 2-deoxy-D-glucose in human tumor cell lines. Ind. J. Expt. Biol. 41: 1392-1399; 2003.
37. Zolzer, F.; Gilbertz, K. and Streffer, C. Correlation of (S±G2) phase fractions determined by flow cytometry and Ki-67 labelling indices in colorectal carcinoma. Oncol. 51: 9-12; 1994.
38. Chandna, S. Single cell electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death. Cytometry 61A: 127-133; 2004.
39. Gong, J.; Traganos, F. and Darzynkiewiez, Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218: 314-319; 1994.
40. Dewey, W.C.; Ling, C.C. and Meyn, R.E. Radiation induced apoptosis: relevence to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33: 781-796; 1995.
41. Lowe, S.W. and Ruley, E.I.A. Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis. Genes. Dev. 7: 535-545; 1993.
42. Strasser, A.; Harris, A.W.; Jacks, T. and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53 dependent mechanisms inhibitable by Bcl2. Cell 79: 329-339; 1994.
43. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933; 2001.
44. Aft, R.L.; Zhang, F.W. and Gius, D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br. J. Cancer 87: 805-812; 2002.
45. Dwarakanath, B.S.; Adhikari, J.S. and Jain, V. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 43: 1125-1133; 1999.
46. Zolzer, F.; Hillebrandt, S. and Streffer, C. radiation induced G1 block and p53 status in six human cell lines. Radiother. Oncol. 37: 20-28; 1995.
47. Lee, Y.J.; Galoforo, S.S.; Berns, C.M.; Tong, W.P.; Kim, H.R.C.; and Corry, P.M. Glucose deprivation induced cytotoxicity in drug resistant human breast carcinoma MCF-7/ADR cells: role of c-myc and Bcl2 in apoptotic cell death. J. Cell Sci. 110: 681-686; 1997.
48. Parone, P.A.; James, D. and Martinou, J.C. Mitochondria: regulating the inevitable. Biochimie 84: 105-111; 2002.
49. Bell, S.E.; Quinn, D.M.; Kellet, G.L. and Warr, J.R. 2-DG preferentially kills MDR human KB carcinoma cells. Br. J. Cancer 78: 1464-1470; 1998.
50. Kalia, V.K.; Jain, V.K. and Otto, F.J. Optimization of cancer therapy: part IV-Effects of 2-deoxy-D-glucose on radiation induced chromosomal damage in PHA stimulated peripheral human leukocytes. Ind. J. Expt. Biol. 20: 884-888; 1982.
51. Singh, S.P.; Singh, S. and Jain, V.K. Effects of 5-bromo-2-deoxyuridine and 2-deoxy-D-glucose on radiation-induced micronuclei in mouse bone marrow. Int. J. Radiat. Biol. 85: 791-797; 1990.
52. Kumarswamy, R.; Manickam, J.; Adhikari, J.S. and Dwarakanath, B.S. The glycolytic inhibitor 2-deoxy-D-glucose does not enhance radiation induced apoptosis in mouse splenocytes and thymocytes in-vitro. Ind. J. Exp. Biol. (In press)
53. Lin, X.; Zhang, C.; Bradbury, C.M.; Kaushal, A.; Li, L.; Spitz, D.R.; Aft, R.L. and Gius, D. 2-deoxy-D-glucose induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res. 63: 3413-3417; 2003.
54. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L. and Korsmeyer, S.J. Bcl2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251; 1993.
55. Dang, C.V., Lewis, B.C., Dolde, C., Dang, G. and Shim, H. J. Bioenerg. Biomembr. 29: 345-354; 1997.
56. Jacoby, D.B., Zilz, N.D. & Towle, H.C. J. Biol. Chem. 264: 17623-17626; 1987.
57. Foufelle, F.; Gouhot, B.; Pegorier, J. P.; Perdereau, D.; Girard, J. and Ferre, P. J. Biol. Chem. 267: 20543-20546; 1992.
58. Sweet, S. and Singh, G. Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res. 55: 5164-5167; 1995.
59. Jimenz, G.S; Khan, S.H; Stommel, J.M. and Wahl, G.M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18: 7656-7665; 1999.
60. Gronostajski, R.M.; Goldberg, A.L. and Pardee, A.B. Energy requirement for degradation of tumor associated protein p53. Mol. Cell Biol. 4: 442-448; 1984.
61. Brown, V.D. and Gallie, B.L. The B domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation. Mol. Cell Biol. 1390-1401; 2002.
62. Saavedra, H.I.; Wu, L.; Bruin, A.D.; Timmers, C.; Rosol, T.J.; Weinstein, M.; Robinson, M.L. and Leone, G. Specificity of E2F1, E2F2 and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Diff. 13: 215-225; 2002.
63. Jain, V, Dwarakanath, B. S., Heminger, K, Kadakia, M, Stapeleton, S, Mantil, J, and Berberich, S. Alterations in gene expression induced due to metabolic stress caused by glucose deprivation and 2-deoxyglucose in malignant glioma cells. J Natl Cancer Inst, In submission; 2004.
64. Heminger, K., Jain, V., Kadakia, M., Dwarakanath, B.S. and Berberich, S. Effects of 2-deoxyglucose on the alterations in gene expression induced by ionizing radiation in a human glioma cell line. J. Mol. Therap. Communicated; 2004.